Integration of individual‐level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer
ABSTRACT Background Strategies to integrate multiple individual‐level social determinants of health (SDOH) remain limited in cardio‐oncology. Methods Across two longitudinal prospective cohorts of 193 women with breast cancer (ClinicalTrials.gov identifier NCT05078190) and 195 men with prostate cancer (ClinicalTrials.gov identifier NCT05096338) who were initiating potentially cardiotoxic cancer therapy, the authors comprehensively assessed 16 individual‐level SDOH (20 effective variables) before treatment initiation. For each cohort, a data‐driven approach using dimensionality reduction by means of factorial analysis of mixed data was conducted. Longitudinal associations between each dimension and cardiovascular risk factors (CVRFs; blood pressure, body mass index, and moderate‐to‐vigorous physical activity [MVPA]) over 12 months were estimated using generalized estimating equations scaled to a 1‐interquartile range increase in the dimension score. As a comparator with individual SDOH measures, associations between CVRFs and the social vulnerability index were assessed. Results In each cohort, six orthogonal dimensions explained nearly 50% of the total variability in SDOH. In breast cancer, dimension 1 (16.4% variability) reflected food insecurity and financial toxicity. Each 1‐interquartile range increase in the dimension 1 score was associated with a 0.3‐kg/m 2 higher body mass index (95% confidence interval [CI], 0.02–0.5 kg/m 2 ) and a 2.5‐point lower MVPA score (95% CI, −4.8, −0.3). In prostate cancer, dimension 1 (16.0% variability) reflected education, occupational prestige, income, employment, and health literacy. Each 1‐interquartile range increase in the dimension 1 score was associated with a 2.6‐point lower MVPA score (95% CI, −4.6, −0.6). The social vulnerability index was not significantly associated with longitudinal changes in CVRFs. Conclusions This work supports a data‐driven approach to integrate multiple individual‐level SDOH measures to inform the associations between multilevel SDOH measures and cardiovascular risk in cancer.
Authors
- Yehoda M. Martei (ORCID: https://orcid.org/0000-0002-5631-1567)
- Kirsten M. M. Beyer (ORCID: https://orcid.org/0000-0002-7513-8528)
- Oluwadamilola M. Fayanju (ORCID: https://orcid.org/0000-0002-0876-975X)
- Amanda M. Smith (ORCID: https://orcid.org/0000-0002-9881-236X)
- Anran Huang (ORCID: https://orcid.org/0000-0003-1435-1576)
- Wonyoung Jung (ORCID: https://orcid.org/0000-0003-4749-4637)
- Daniel Koropeckyj-Cox (ORCID: https://orcid.org/0009-0009-6446-3868)
- Kyunga Ko (ORCID: https://orcid.org/0000-0001-8582-2633)
- Lin Mei
- Kelly Getz
- Kellie McDermott
- Congying Xia
- Bonnie Ky
- Amy Clark (ORCID: https://orcid.org/0000-0002-3685-6535)
- Gary Hettinger
- Carmen E. Guerra
- Samuel Takvorian
- Sanchit Kumar
- Vivek Narayan
- Clyde Yancy
- Tiffany Powell‐Wiley
- Javier Sierra Pagan
- Yong‐Moon Mark Park
Institutions
- Northwestern University (US)
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- National Heart, Lung, and Blood Institute (US)
- Winthrop Rockefeller Foundation (US)
- National Institute on Minority Health and Health Disparities (US)
- New York University (US)
- University of Pennsylvania (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Cancer
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1002/cncr.70674
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00